COL6A6 Peptide Vaccine Alleviates Atherosclerosis through Inducing Immune Response and Regulating Lipid Metabolism in Apoe−/− Mice
Cells · 2024
DOI: 10.3390/cells13181589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Dongmei Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Key Lab for Shock and Microcirculation Research of Guangdong, School of Basic Medical Sciences, Southern Medical Unive…. Hauptthemen laut MEDLINE: Atherosclerosis, Lipid Metabolism, Apolipoproteins E, Vaccines, Subunit. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Natural Science Foundation of Guangdong, the Guangdong Province Talent Recruitment Foundation and the Guangdong Innovative Research Team Program.
Abstract (Originalsprache)
Atherosclerosis is an autoimmune disease characterized by lipid imbalances and chronic inflammation within blood vessels, with limited preventive and treatment options currently available. In this study, a vaccine prepared with COL6A6 peptide (named the Pep_A6 vaccine) was administered to immunize Apoe−/− mice, and the immune mechanism of the Pep_A6 vaccine against atherosclerosis was first investigated. The results of arterial oil red O staining demonstrated that the Pep_A6 vaccine significantly reduced the atherosclerotic plaque area in Apoe−/− mice fed with a high-fat diet for 20 weeks. A flow cytometry analysis revealed that the Pep_A6 vaccine inhibited Th1 cell differentiation and increased the proportion of Treg cells. Furthermore, there was a significant increase in Ly6Clow monocytes observed in the vaccinated group. The ELISA results showed that the Pep_A6 vaccine induced a significant expression of Pep_A6-specific antibody IgG and IgG1 in mouse serum. Additionally, we found that the Pep_A6 vaccine significantly decreased serum LDL-C content and regulated the expression of genes related to liver lipid metabolism. Together, our findings suggest that the Pep_A6 vaccine alleviates atherosclerosis by inducing a positive immune response and regulating lipid metabolism, providing new insights into potential prevention strategies for atherosclerosis as an innovative vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, Key Lab for Shock and Microcirculation Research of Guangdong, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
Förderung
- National Natural Science Foundation of China
- the Natural Science Foundation of Guangdong
- the Guangdong Province Talent Recruitment Foundation and the Guangdong Innovative Research Team Program
- Guangzhou Science and technology project
- Natural Science Foundation of Guangdong, China
- Guangdong Province Talent Recruitment Foundation and the Guangdong Innovative Research Team Program
Zitieren
APA
Tang, D., Liu, Y., Duan, R., Lin, R., Li, Z., Liu, X., Huang, J., & Zhao, M. (2024). COL6A6 Peptide Vaccine Alleviates Atherosclerosis through Inducing Immune Response and Regulating Lipid Metabolism in Apoe−/− Mice. Cells. https://doi.org/10.3390/cells13181589
Vancouver
Tang D, Liu Y, Duan R, Lin R, Li Z, Liu X, et al. COL6A6 Peptide Vaccine Alleviates Atherosclerosis through Inducing Immune Response and Regulating Lipid Metabolism in Apoe−/− Mice. Cells. 2024. doi:10.3390/cells13181589
BibTeX
@article{Tang2024,
author = {Tang, Dongmei and Liu, Yan and Duan, Rui and Lin, Run and Li, Zhonghao and Liu, Xianyan and Huang, Jingrong and Zhao, Ming},
title = {COL6A6 Peptide Vaccine Alleviates Atherosclerosis through Inducing Immune Response and Regulating Lipid Metabolism in Apoe−/− Mice},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13181589}
}
EUVIMED